TROUGH LEVELS TO INFLIXIMAB AT W6 ARE PREDICTIVE OF REMISSION AT W14, IN PEDIATRIC CROHN DISEASE.
Christine Martinez-Vinson 1
Olivier Courbette 1
Camille Aupiais 1
Jérome Viala 1
Jean-Pierre Hugot 1
1 Hôpital Robert Debré,Gastroentérologie pédiatrique,Paris,France
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu
Social Sharing